Literature DB >> 17446430

The Virtual International Stroke Trials Archive.

Myzoon Ali1, Philip M W Bath, John Curram, Stephen M Davis, Hans-Christoph Diener, Geoffrey A Donnan, Marc Fisher, Barbara A Gregson, James Grotta, Werner Hacke, Michael G Hennerici, Marc Hommel, Markku Kaste, John R Marler, Ralph L Sacco, Philip Teal, Nils-Gunnar Wahlgren, Steven Warach, Christopher J Weir, Kennedy R Lees.   

Abstract

BACKGROUND AND
PURPOSE: Stroke has global importance and it causes an increasing amount of human suffering and economic burden, but its management is far from optimal. The unsuccessful outcome of several research programs highlights the need for reliable data on which to plan future clinical trials. The Virtual International Stroke Trials Archive aims to aid the planning of clinical trials by collating and providing access to a rich resource of patient data to perform exploratory analyses.
METHODS: Data were contributed by the principal investigators of numerous trials from the past 16 years. These data have been centrally collated and are available for anonymized analysis and hypothesis testing.
RESULTS: Currently, the Virtual International Stroke Trials Archive contains 21 trials. There are data on >15,000 patients with both ischemic and hemorrhagic stroke. Ages range between 18 and 103 years, with a mean age of 69+/-12 years. Outcome measures include the Barthel Index, Scandinavian Stroke Scale, National Institutes of Health Stroke Scale, Orgogozo Scale, and modified Rankin Scale. Medical history and onset-to-treatment time are readily available, and computed tomography lesion data are available for selected trials.
CONCLUSIONS: This resource has the potential to influence clinical trial design and implementation through data analyses that inform planning.

Entities:  

Mesh:

Year:  2007        PMID: 17446430     DOI: 10.1161/STROKEAHA.106.473579

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  33 in total

1.  Robotic measurement of arm movements after stroke establishes biomarkers of motor recovery.

Authors:  Hermano I Krebs; Michael Krams; Dimitris K Agrafiotis; Allitia DiBernardo; Juan C Chavez; Gary S Littman; Eric Yang; Geert Byttebier; Laura Dipietro; Avrielle Rykman; Kate McArthur; Karim Hajjar; Kennedy R Lees; Bruce T Volpe
Journal:  Stroke       Date:  2013-12-12       Impact factor: 7.914

Review 2.  The Subarachnoid Hemorrhage International Trialists (SAHIT) Repository: advancing clinical research in subarachnoid hemorrhage.

Authors:  Blessing N R Jaja; Daniel Attalla; R Loch Macdonald; Tom A Schweizer; Michael D Cusimano; Nima Etminan; Daniel Hanggi; David Hasan; S Claiborne Johnston; Peter Le Roux; Benjamin Lo; Ada Louffat-Olivares; Stephan Mayer; Andrew Molyneux; Adam Noble; Audrey Quinn; Thomas Schenk; Julian Spears; Jeffrey Singh; Michael Todd; James Torner; Ming Tseng; William van den Bergh; Mervyn D I Vergouwen; George K C Wong
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

Review 3.  Stroke imaging research road map.

Authors:  Carlos Leiva-Salinas; Jason Hom; Steven Warach; Max Wintermark
Journal:  Neuroimaging Clin N Am       Date:  2011-03-15       Impact factor: 2.264

4.  Disability status at 1 month is a reliable proxy for final ischemic stroke outcome.

Authors:  Bruce Ovbiagele; Patrick D Lyden; Jeffrey L Saver
Journal:  Neurology       Date:  2010-08-24       Impact factor: 9.910

5.  Interruption to antiplatelet therapy early after acute ischaemic stroke: a nested case-control study.

Authors:  Wardati Mazlan-Kepli; Rachael L Macisaac; Matthew Walters; Philip Michael William Bath; Jesse Dawson
Journal:  Br J Clin Pharmacol       Date:  2017-04-20       Impact factor: 4.335

6.  A Pilot Trial of Low-Dose Intravenous Abciximab and Unfractionated Heparin for Acute Ischemic Stroke: Translating GP IIb/IIIa Receptor Inhibition to Clinical Practice.

Authors:  Pitchaiah Mandava; William Dalmeida; Jane A Anderson; Perumal Thiagarajan; Roderic H Fabian; Raymond U Weir; Thomas A Kent
Journal:  Transl Stroke Res       Date:  2010-09       Impact factor: 6.829

Review 7.  SAHIT Investigators--on the outcome of some subarachnoid hemorrhage clinical trials.

Authors:  R Loch Macdonald; Blessing Jaja; Michael D Cusimano; Nima Etminan; Daniel Hanggi; David Hasan; Don Ilodigwe; Hector Lantigua; Peter Le Roux; Benjamin Lo; Ada Louffat-Olivares; Stephan Mayer; Andrew Molyneux; Audrey Quinn; Tom A Schweizer; Thomas Schenk; Julian Spears; Michael Todd; James Torner; Mervyn D I Vergouwen; George K C Wong; Jeff Singh
Journal:  Transl Stroke Res       Date:  2013-01-07       Impact factor: 6.829

8.  Comparison of outcomes following thrombolytic therapy among patients with prior stroke and diabetes in the Virtual International Stroke Trials Archive (VISTA).

Authors:  Nishant Kumar Mishra; Stephen M Davis; Markku Kaste; Kennedy R Lees
Journal:  Diabetes Care       Date:  2010-09-15       Impact factor: 19.112

9.  Rate of perihaematomal oedema expansion is associated with poor clinical outcomes in intracerebral haemorrhage.

Authors:  Santosh B Murthy; Sebastian Urday; Lauren A Beslow; Jesse Dawson; Kennedy Lees; W Taylor Kimberly; Costantino Iadecola; Hooman Kamel; Daniel F Hanley; Kevin N Sheth; Wendy C Ziai
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-07-27       Impact factor: 10.154

10.  Relationship between temperature, hematoma growth, and functional outcome after intracerebral hemorrhage.

Authors:  Fred Rincon; Patrick Lyden; Stephan A Mayer
Journal:  Neurocrit Care       Date:  2013-02       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.